跳至主要内容
临床试验/JPRN-jRCT1061220024
JPRN-jRCT1061220024进行中(未招募)未知

ew biomarker HRG (Histidine-Rich Glycoprotein) that enables early diagnosis and severity assessment of sepsis

Morimatsu Hiroshi0 个研究点目标入组 150 人开始时间: 2022年6月4日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1 Inpatients who visited the emergency outpatient department of Okayama University Hospital or a joint research institute between March 31, 2023 after the approval of the Institutional Review Board and met two or more qSOFA criteria
  • 2 Patients who can voluntarily obtain consent to participate in the study in writing from the person or his / her surrogate

排除标准

  • 1 Under 18 years old
  • 2 Pregnant woman
  • 3 Patients after resuscitation with cardiopulmonary arrest
  • 4 Patients transferred from another hospital
  • 5 Patients who are considered inappropriate for study for other reasons

研究者

发起方
Morimatsu Hiroshi

相似试验